NCT02910349View on ClinicalTrials.gov

Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2021

Study Completion Date

December 31, 2021

Conditions
Aortic Valve Disorder
Trial Locations (5)

14000

Institute for Clinical and Experimental Medicine, Prague

50005

Karel Medilek, M.D., Hradec Králové

Unknown

VZW Cardiovascular Research Center Aalst, Aalst

Faculty Hospital Kralovske Vinohrady, Prague

General University Hospital, Prague

All Listed Sponsors
collaborator

Faculty Hospital Kralovske Vinohrady

OTHER_GOV

collaborator

General University Hospital, Prague

OTHER

collaborator

VZW Cardiovascular Research Center Aalst

OTHER

collaborator

University Hospital Hradec Kralove

OTHER

lead

Institute for Clinical and Experimental Medicine

OTHER_GOV

NCT02910349 - Novel Cardiac Imaging Prognostic Markers of Clinical Outcome in Patients With Chronic Aortic Regurgitation | Biotech Hunter | Biotech Hunter